294 related articles for article (PubMed ID: 25944318)
1. Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy.
Hattab S; Guiguet M; Carcelain G; Fourati S; Guihot A; Autran B; Caby F; Marcelin AG; Costagliola D; Katlama C
HIV Med; 2015 Oct; 16(9):553-62. PubMed ID: 25944318
[TBL] [Abstract][Full Text] [Related]
2. Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study.
Hattab S; Guihot A; Guiguet M; Fourati S; Carcelain G; Caby F; Marcelin AG; Autran B; Costagliola D; Katlama C
BMC Infect Dis; 2014 Mar; 14():122. PubMed ID: 24589015
[TBL] [Abstract][Full Text] [Related]
3. A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.
Kamat A; Misra V; Cassol E; Ancuta P; Yan Z; Li C; Morgello S; Gabuzda D
PLoS One; 2012; 7(2):e30881. PubMed ID: 22363505
[TBL] [Abstract][Full Text] [Related]
4. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
Bastard JP; Soulié C; Fellahi S; Haïm-Boukobza S; Simon A; Katlama C; Calvez V; Marcelin AG; Capeau J
Antivir Ther; 2012; 17(5):915-9. PubMed ID: 22436412
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?
Castley A; Berry C; French M; Fernandez S; Krueger R; Nolan D
PLoS One; 2014; 9(12):e115226. PubMed ID: 25544986
[TBL] [Abstract][Full Text] [Related]
6. Effects of Tobacco Usage and Antiretroviral Therapy on Biomarkers of Systemic Immune Activation in HIV-Infected Participants.
Steel HC; Venter WDF; Theron AJ; Anderson R; Feldman C; Kwofie L; Cronjé T; Arullapan N; Rossouw TM
Mediators Inflamm; 2018; 2018():8357109. PubMed ID: 30622435
[TBL] [Abstract][Full Text] [Related]
7. Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression.
Thiébaut R; Charpentier C; Damond F; Taieb A; Antoine R; Capeau J; Chêne G; Collin G; Matheron S; Descamps D; Brun-Vézinet F;
Clin Infect Dis; 2012 Nov; 55(10):1417-25. PubMed ID: 22911639
[TBL] [Abstract][Full Text] [Related]
8. The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up.
Carsenti-Dellamonica H; Saïdi H; Ticchioni M; Guillouet de Salvador F; Dufayard Cottalorda J; Garraffo R; Dellamonica P; Durant J; Gougeon ML
HIV Med; 2011 Feb; 12(2):65-77. PubMed ID: 20500532
[TBL] [Abstract][Full Text] [Related]
9. Systemic Immune Activation Profiles of HIV-1 Subtype C-Infected Children and Their Mothers.
Makhubele TG; Steel HC; Anderson R; van Dyk G; Theron AJ; Rossouw TM
Mediators Inflamm; 2016; 2016():9026573. PubMed ID: 27019552
[TBL] [Abstract][Full Text] [Related]
10. Low levels of microbial translocation marker LBP are associated with sustained viral response after anti-HCV treatment in HIV-1/HCV co-infected patients.
Nyström J; Stenkvist J; Häggblom A; Weiland O; Nowak P
PLoS One; 2015; 10(3):e0118643. PubMed ID: 25785448
[TBL] [Abstract][Full Text] [Related]
11. Anaemia is associated with monocyte activation in HIV-infected adults on antiretroviral therapy.
Lipshultz HM; Hileman CO; Ahuja S; Funderburg NT; McComsey GA
Antivir Ther; 2015; 20(5):521-7. PubMed ID: 25668820
[TBL] [Abstract][Full Text] [Related]
12. Long-term suppressive combined antiretroviral treatment does not normalize the serum level of soluble CD14.
Méndez-Lagares G; Romero-Sánchez MC; Ruiz-Mateos E; Genebat M; Ferrando-Martínez S; Muñoz-Fernández MÁ; Pacheco YM; Leal M
J Infect Dis; 2013 Apr; 207(8):1221-5. PubMed ID: 23322858
[TBL] [Abstract][Full Text] [Related]
13. Rapid suppression of HIV-RNA is associated with improved control of immune activation in Mozambican adults initiating antiretroviral therapy with low CD4 counts.
Almeida JM; Letang E; Nhampossa T; Ayala E; David C; Menendez C; Gascon J; Alonso P; Naniche D
AIDS Res Hum Retroviruses; 2011 Jul; 27(7):705-11. PubMed ID: 21091388
[TBL] [Abstract][Full Text] [Related]
14. Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.
Castillo-Mancilla JR; Brown TT; Erlandson KM; Palella FJ; Gardner EM; Macatangay BJ; Breen EC; Jacobson LP; Anderson PL; Wada NI
Clin Infect Dis; 2016 Dec; 63(12):1661-1667. PubMed ID: 27660234
[TBL] [Abstract][Full Text] [Related]
15. Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients.
Casado JL; Abad-Fernández M; Moreno S; Pérez-Elías MJ; Moreno A; Bernardino JI; Vallejo A
HIV Med; 2015 Apr; 16(4):240-8. PubMed ID: 25604328
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy.
Ndumbi P; Gillis J; Raboud J; Cooper C; Hogg RS; Montaner JS; Burchell AN; Loutfy MR; Machouf N; Klein MB; Tsoukas C;
HIV Med; 2014 Mar; 15(3):153-64. PubMed ID: 24304582
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Biomarkers and Mortality Risk Among HIV-Suppressed Men: A Multisite Prospective Cohort Study.
Wada NI; Bream JH; Martínez-Maza O; Macatangay B; Galvin SR; Margolick JB; Jacobson LP
Clin Infect Dis; 2016 Oct; 63(7):984-990. PubMed ID: 27343547
[TBL] [Abstract][Full Text] [Related]
18. Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection.
de Paula HHS; Ferreira ACG; Caetano DG; Delatorre E; Teixeira SLM; Coelho LE; João EG; de Andrade MM; Cardoso SW; Grinsztejn B; Veloso VG; Morgado MG; Guimarães ML; Côrtes FH
Retrovirology; 2018 Dec; 15(1):76. PubMed ID: 30541557
[TBL] [Abstract][Full Text] [Related]
19. Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy.
Kroeze S; Wit FW; Rossouw TM; Steel HC; Kityo CM; Siwale M; Akanmu S; Mandaliya K; de Jager M; Ondoa P; Reiss P; Rinke de Wit TF; Kootstra N; Hamers RL
J Infect Dis; 2019 Aug; 220(6):1029-1033. PubMed ID: 31086991
[TBL] [Abstract][Full Text] [Related]
20. Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities.
Ghislain M; Bastard JP; Meyer L; Capeau J; Fellahi S; Gérard L; May T; Simon A; Vigouroux C; Goujard C;
PLoS One; 2015; 10(12):e0144317. PubMed ID: 26636578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
